Quit Smoking & TGA Guidance
At Kicko, we provide evidence-based support to help you quit smoking and reduce nicotine dependence safely and effectively.
Our clinician-led telehealth services are designed in line with Australian medical standards and structured around the Therapeutic Goods Administration (TGA) regulatory framework.
Understanding the regulations
In Australia, nicotine vaping products and other smoking cessation aids are subject to strict TGA regulation.
These products are managed through medical pathways to support adults who are trying to quit smoking or manage nicotine dependence under clinical supervision.
Prescribers are guided by TGA and clinical guidelines when considering vaping products or other therapies for smoking cessation or nicotine dependence.
Why this matters for your quit journey
Australia’s TGA regulations are designed to protect public health while enabling legitimate access to clinical options for quitting smoking. Because of these requirements:
Nicotine vaping products aren’t considered first-line treatments - they may be recommended only when other approved methods haven’t worked.
Access pathways like authorised prescriber and Special Access Scheme routes ensure safe, tailored prescribing.
What you need to know
Quitting smoking and cutting nicotine dependence can look different for everyone.
Some people benefit from standard TGA-approved therapies like nicotine replacement patches or gum, while others may explore additional clinical options under professional guidance.
Our clinical team will work with you to find the most suitable path based on your history, goals, and the best available guidance, always prioritising your safety and long-term wellbeing.
Ready to get started with Kicko?
Kicko makes it simple: begin with our 30-second pre-screen, and our nurse will follow up to start your personalised quit plan.
Our care is delivered with full respect for Australian regulatory requirements and clinical standards.
Let’s make quitting smoking manageable with support that meets you where you are.
Currently, no nicotine vaping products have been approved by the Therapeutic Goods Administration (TGA) and included on the Australian Register of Therapeutic Goods (ARTG) for smoking cessation or managing nicotine dependence.
Products not on the ARTG are classified as unapproved therapeutic goods and have not been formally assessed by the TGA for safety, quality, or therapeutic effectiveness. In Australia, nicotine vaping products can be legally accessed only through regulated pathways - such as a valid prescription or authorised prescriber route and healthcare practitioners must carefully weigh the available evidence and individual patient risks before prescribing them.
Got more questions?
You don’t have to do it alone. Speak with an experienced team member who understands nicotine dependence and can answer all your questions.